Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27–45 years of age compared to women 16–26 years of age: An open-label phase 3 study-Reference-Cited by-同舟云学术

Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27–45 years of age compared to women 16–26 years of age: An open-label phase 3 study

Published:2021-05 Issue:20 Volume:39 Page:2800-2809
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Joura Elmar A.,Ulied Angels,Vandermeulen Corinne,Rua Figueroa Milagrosa,Seppä Ilkka,Hernandez Aguado Juan José,Ahonen Anitta,Reich Olaf,Virta Miia,Perino Antonino,Peris Tuser Merce,Peters Klaus,Origoni Massimo,Raspagliesi Francesco,Tjalma Wiebren A.A.,Tummers Philippe,Woelber Linn,Nieminen Pekka^ORCID,van Damme Pierre,Sehouli Jalid,Fiol Ruiz Gabriel,Brucker Sara^ORCID,Fehm Tanja,Cheon Kyeongmi,Rawat Sonali,Luxembourg Alain,Wittke Frederick

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference50 articles.

1. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis;de Martel;Lancet Glob Health,2020

2. Global burden of cancers attributable to infections in 2012: a synthetic analysis;Plummer;Lancet Glob Health,2016

3. 9-valent human papillomavirus vaccine: a review of the clinical development program;Luxembourg;Expert Rev Vaccines,2017

4. A review of clinical trials of human papillomavirus prophylactic vaccines;Schiller;Vaccine,2012

5. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions;Serrano;Eur J Cancer,2015

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the seroprevalence of human papillomavirus in Guangdong, China: Implications for vaccination strategies;Journal of Medical Virology;2024-09

2. The Non-inferiority of Human Papillomavirus Vaccine Immunogenicity Among Women Over 26 Years: A Systematic Review;Cureus;2024-07-22

3. Oral HPV infection clearance and acquisition after nonavalent vaccination in men who have sex with men and transgender women: a prospective analysis;European Journal of Clinical Microbiology & Infectious Diseases;2024-07-02

4. Understanding the HPV associated cancers: A comprehensive review;Molecular Biology Reports;2024-06-14

5. The Role and Development of Peptide Vaccines in Cervical Cancer Treatment;International Journal of Peptide Research and Therapeutics;2024-05-24